Discover how lifestyle interventions, particularly achieving a weight loss of over 10%, have been shown to resolve MASH.

On January 6, 2025, the U.S. Food and Drug Administration (“FDA”) and the Office for Human Research Protections (“OHRP”) issued a joint draft ...

Owlstone Medical has secured the first closing of its Series E financing round, securing $27m (approximately £22m) to advance ...

Owlstone Medical, the Cambridge-based global leader in Breath Biopsy® for applications in early disease detection and ...

Learn what liver pain means for your health, its causes, symptoms, and effective treatments. Understand when to seek medical ...